- Home
- WST vs EL Comparison
WST vs EL Comparison
Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- EL
- Stock Information
- Founded
- WST 1923
- EL 1946
- Country
- WST United States
- EL United States
- Employees
- WST N/A
- EL N/A
- Industry
- WST Medical/Dental Instruments
- EL Package Goods/Cosmetics
- Sector
- WST Health Care
- EL Consumer Discretionary
- Exchange
- WST Nasdaq
- EL Nasdaq
- Market Cap
- WST 15.6B
- EL 24.8B
- IPO Year
- WST N/A
- EL 1995
- Fundamental
- Price
- WST $222.83
- EL $85.85
- Analyst Decision
- WST Buy
- EL Buy
- Analyst Count
- WST 7
- EL 20
- Target Price
- WST $331.67
- EL $73.53
- AVG Volume (30 Days)
- WST 645.3K
- EL 5.0M
- Earning Date
- WST 07-24-2025
- EL 08-20-2025
- Dividend Yield
- WST 0.38%
- EL 1.64%
- EPS Growth
- WST N/A
- EL N/A
- EPS
- WST 6.37
- EL N/A
- Revenue
- WST $2,895,800,000.00
- EL $14,786,000,000.00
- Revenue This Year
- WST $3.38
- EL N/A
- Revenue Next Year
- WST $5.85
- EL $1.82
- P/E Ratio
- WST $34.63
- EL N/A
- Revenue Growth
- WST N/A
- EL N/A
- 52 Week Low
- WST $187.43
- EL $48.37
- 52 Week High
- WST $352.33
- EL $107.29
- Technical
- Relative Strength Index (RSI)
- WST 54.71
- EL 71.33
- Support Level
- WST $219.60
- EL $84.58
- Resistance Level
- WST $225.46
- EL $89.86
- Average True Range (ATR)
- WST 4.88
- EL 2.72
- MACD
- WST -0.09
- EL 0.49
- Stochastic Oscillator
- WST 63.62
- EL 76.10
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.